相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation
Hiroshi Fukamachi et al.
CANCER SCIENCE (2011)
Current molecular markers for gastric progenitor cells and gastric cancer stem cells
Xiaotan T. Qiao et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Cancer Stem Cells: Characteristics and Their Potential Role for New Therapeutic Strategies
Stephan R. Bohl et al.
ONKOLOGIE (2011)
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
Po Zhao et al.
BMC CANCER (2010)
Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
Ji-wei Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
CD133 mRNA Expression and Microsatellite Instability in Colorectal Carcinoma
Jung Wook Huh et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
CD133 expression in different stages of gastric adenocarcinoma
M. Boegl et al.
BRITISH JOURNAL OF CANCER (2009)
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer
Virginia Tirino et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Targeting CD133 antigen in cancer
Gabriella Ferrandina et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L. M. Smith et al.
BRITISH JOURNAL OF CANCER (2008)
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
D. Horst et al.
BRITISH JOURNAL OF CANCER (2008)
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
S. Maeda et al.
BRITISH JOURNAL OF CANCER (2008)
Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
Motohiro Kojima et al.
CANCER SCIENCE (2008)
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
W. Song et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Jun Miki et al.
CANCER RESEARCH (2007)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer
Young-Eun Joo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer
W Hilbe et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
分享论文
